SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

被引：0
|
作者：
Constanze Schneider
Thomas Oellerich
Hanna-Mari Baldauf
Sarah-Marie Schwarz
Dominique Thomas
Robert Flick
Hanibal Bohnenberger
Lars Kaderali
Lena Stegmann
Anjali Cremer
Margarethe Martin
Julian Lohmeyer
Martin Michaelis
Veit Hornung
Christoph Schliemann
Wolfgang E Berdel
Wolfgang Hartmann
Eva Wardelmann
Federico Comoglio
Martin-Leo Hansmann
Alexander F Yakunin
Gerd Geisslinger
Philipp Ströbel
Nerea Ferreirós
Hubert Serve
Oliver T Keppler
Jindrich Cinatl
机构：
[1] Institute of Medical Virology,Department of Medicine II
[2] University of Frankfurt,Cambridge University Department of Haematology
[3] Hematology and Oncology,Department of Virology
[4] ,Department of Chemical Engineering and Applied Chemistry
[5] Goethe University of Frankfurt,Gene Center and Department of Biochemistry
[6] Cambridge Institute of Medical Research,Department of Medicine A (Hematology
[7] German Cancer Consortium partner site,undefined
[8] German Cancer Research Center,undefined
[9] Max von Pettenkofer Institute,undefined
[10] Ludwig Maximilian University of Munich,undefined
[11] Pharmazentrum frankfurt/ZAFES,undefined
[12] ,undefined
[13] Institute of Clinical Pharmacology,undefined
[14] Goethe University of Frankfurt,undefined
[15] University of Toronto,undefined
[16] Institute of Pathology,undefined
[17] University Medical Center,undefined
[18] Institute of Bioinformatics,undefined
[19] University Medicine Greifswald,undefined
[20] Centre for Molecular Processing and School of Biosciences,undefined
[21] University of Kent,undefined
[22] Institute of Molecular Medicine,undefined
[23] University Hospital Bonn,undefined
[24] Ludwig Maximilian University of Munich,undefined
[25] Oncology),undefined
[26] University Hospital Münster,undefined
[27] Gerhard Domagk Institute for Pathology,undefined
[28] University Hospital Münster,undefined
[29] Senckenberg Institute of Pathology,undefined
[30] University of Frankfurt,undefined
[31] Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),undefined
[32] Project Group Translational Medicine and Pharmacology (TMP),undefined
来源：
Nature Medicine | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The therapeutic response of acute myeloid leukemia to the nucleoside analog Ara-C is controlled by SAMHD1, an enzyme that hydrolyzes the active metabolite Ara-CTP.
引用
收藏
页码：250 / 255
页数：5
相关论文
共 50 条
  • [41] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [42] Potential new therapeutic target to treat acute myeloid leukemia
    Wraight, Sophie
    EXPERT REVIEW OF PROTEOMICS, 2013, 10 (02) : 124 - 124
  • [43] The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia
    Tan, Su-Fern
    Pearson, Jennifer M.
    Feith, David J.
    Loughran, Thomas P., Jr.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (06) : 583 - 590
  • [44] JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia
    Venugopal, Sangeetha
    Bar-Natan, Michal
    Mascarenhas, John O.
    BLOOD REVIEWS, 2020, 40
  • [45] Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia
    Shallis, Rory M.
    Bewersdorf, Jan Philipp
    Boddu, Prajwal C.
    Zeidan, Amer M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (08) : 717 - 729
  • [46] Identification of TIFA as a novel therapeutic target in acute myeloid leukemia
    Wu, Pei-Yu
    Wei, Tong-You Wade
    Wu, Ting-Jung
    Tsai, Ming-Daw
    CANCER RESEARCH, 2017, 77
  • [47] Potential new therapeutic target to treat acute myeloid leukemia
    Wraight, Sophie
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 120 - 120
  • [48] Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia
    Tabe, Yoko
    Tafuri, Agostino
    Sekihara, Kazumasa
    Yang, Haeun
    Konopleva, Marina
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (07) : 705 - 714
  • [49] SIRT5 As a Therapeutic Target in Acute Myeloid Leukemia
    Yan, Dongqing
    Pomicter, Anthony D.
    Heaton, William L.
    Mason, Clint C.
    Ahmann, Jonathan
    Senina, Anna
    Franzini, Anca
    Halverson, Brayden
    Hein Than
    Clair, Phillip M.
    Khorashad, Jamshid S.
    O'Hare, Thomas
    Deininger, Michael W.
    BLOOD, 2018, 132
  • [50] MITOCHONDRIAL DYNAMICS AS A POTENTIAL THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
    Kinoshita, Mariko
    Saito, Yusuke
    Otani, Kento
    Uehara, Yuya
    Nagasawa, Shun
    Nakagawa, Midori
    Yamada, Ai
    Kamimura, Sachiyo
    Moritake, Hiroshi
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S89 - S90
12345